Monovalent hookworm vaccine - Sabin Vaccine InstituteAlternative Names: Na-APR-1 (M74); Na-APR-1 (M74)/Alhydrogel®; Na-APR-1 hookworm vaccine; Necator americanus Aspartic Protease-1
Latest Information Update: 16 Feb 2017
At a glance
- Originator Sabin Vaccine Institute
- Class Parasitic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Hookworm infections
Most Recent Events
- 15 Feb 2017 Phase I development is ongoing (Sabin Vaccine Institute website, February 2017)